Autosomal Recessive Charcot-Marie-Tooth Disease Type 2 Due to SPG11 (Spatacsin) Mutation

Autosomal recessive Charcot-Marie-Tooth disease type 2 due to SPG11 (spatacsin) mutation is a very rare inherited nerve disease. It mainly damages the long “wires” of the nerves (axons) in the arms and legs. It is called type 2 because the main problem is in the axon, not in the myelin covering. “Autosomal recessive” means a child must get one faulty copy of the SPG11 gene from each parent to develop the disease. The illness usually begins in childhood or young adult life, and gets worse slowly over many years, causing weakness, wasting and numbness in the feet and hands. NCBI+1

The SPG11 gene gives instructions to make a protein called spatacsin. This protein is active in many parts of the nervous system and helps nerve cells move small sacs (vesicles) and waste products inside the cell. It also helps keep long nerve fibers healthy. When both copies of the SPG11 gene are changed (mutated), spatacsin does not work properly. Over time, this leads to damage of the long nerves in the legs and arms, and in many patients also to changes in the brain’s wiring (such as a thin corpus callosum). MedlinePlus+2NCBI+2

Many SPG11 mutations first became known as a cause of hereditary spastic paraplegia type 11 (SPG11-HSP) and juvenile ALS. Later, doctors found families where the main problem was a CMT type 2-like axonal neuropathy, now classified as Charcot-Marie-Tooth disease axonal type 2X (CMT2X). This tells us that SPG11 can cause a spectrum of diseases, with different mixes of leg stiffness, weakness and nerve damage in each person. PMC+2MDPI+2

---

Another names

This same condition can appear under several names in the medical literature and databases. Knowing these names helps when searching reports and genetic results. Common alternative names include:

1. Charcot-Marie-Tooth disease, axonal, type 2X (CMT2X) – the main formal disease name used in genetic catalogs. MalaCards+1

2. Autosomal recessive Charcot-Marie-Tooth disease type 2X – this stresses the inheritance pattern and the axonal nature of the neuropathy. MalaCards+1

3. Autosomal recessive Charcot-Marie-Tooth disease type 2 due to SPG11 mutation – this form makes clear that SPG11 is the causative gene. Orpha

4. Charcot-Marie-Tooth neuropathy type 2X – another way to say CMT2X, focusing on the neuropathy. MalaCards

5. SPG11-related axonal Charcot-Marie-Tooth disease – used in some articles describing CMT as one part of the SPG11 disease spectrum. PMC+1

---

Types

Because SPG11 can affect both peripheral nerves and parts of the brain and spinal cord, doctors see several overlapping clinical types. All share the same basic genetic cause but with different signs and severity.

1. Pure peripheral CMT2X type
   In this type, the main problem is a slowly progressive axonal sensorimotor neuropathy. Weakness and wasting start in the feet and lower legs, with later involvement of the hands. There may be little or no stiffness (spasticity) and brain imaging may be normal or show only mild changes. MalaCards+1

2. CMT2X with pyramidal signs (mixed CMT–HSP type)
   Here, the person has both CMT-like distal weakness and signs of corticospinal tract damage, such as increased reflexes, ankle clonus or leg stiffness. Walking can be affected both by foot drop and by spasticity, and MRI may show a thin corpus callosum. PMC+1

3. CMT2X with thin corpus callosum and cognitive features
   Some SPG11 patients show a marked thinning of the corpus callosum (the bridge between the two brain hemispheres) on MRI. They may develop mild problems with thinking speed, planning, or behavior, plus the peripheral neuropathy. This pattern overlaps strongly with classic SPG11 hereditary spastic paraplegia. PMC+1

4. Juvenile-onset CMT2X type
   Symptoms begin in childhood or early teenage years, often before age 20. Children may be picked up because of frequent tripping, clumsiness in sports, or visible foot deformities. The course is usually slowly progressive over decades, but disability in adult life can be significant. MalaCards+1

5. Adult-onset CMT2X type
   In some families, weakness and sensory loss appear first in the 20s, 30s or later. Because symptoms start later and progress slowly, the disease may be misdiagnosed as acquired neuropathy for many years until genetic testing is done. MalaCards+1

6. CMT2X with ALS-like lower motor neuron features
   Very rarely, SPG11 mutations present mostly as lower motor neuron weakness in limbs, resembling juvenile ALS, together with axonal neuropathy. These cases support the idea that SPG11 mutations can affect several types of motor neurons along one broad spectrum. PubMed+1

---

Causes

Remember that the true root cause of this disease is having two pathogenic SPG11 mutations. The items below explain different genetic and biological mechanisms, and factors that can modify how the disease looks and how severe it becomes.

1. Biallelic pathogenic SPG11 variants
   The main cause is inheriting a harmful SPG11 mutation from each parent. Each parent is usually healthy but carries one faulty copy. When a child receives both faulty copies, spatacsin function is greatly reduced or lost, leading to progressive nerve damage. PMC+1

2. Truncating mutations (nonsense or frameshift)
   Many SPG11 mutations introduce a premature stop signal in the gene. This produces a shorter, non-working protein or no protein at all, causing strong loss-of-function and early, severe neuropathy and spasticity in some families. PMC+1

3. Missense mutations in key domains
   Some patients have missense changes, where one amino acid in spatacsin is swapped for another. If the change is in a critical functional domain, it can disturb vesicle trafficking or axonal maintenance, leading to a milder but still progressive CMT2X phenotype. PMC+1

4. Splice-site mutations
   Mutations at splice sites can cause incorrect cutting and joining of SPG11 RNA. This leads to abnormal or missing parts of the protein. The resulting faulty spatacsin cannot support normal vesicle movement and autophagy in neurons. PMC+1

5. Large deletions or duplications involving SPG11
   Some people have larger structural changes that delete several exons or copy parts of the gene. These structural variants also result in loss of normal spatacsin and can cause CMT2X or SPG11-HSP. PMC+1

6. Impaired endosome–lysosome trafficking
   Spatacsin forms a complex with other proteins that attach to late endosomes and lysosomes. When spatacsin is missing, this complex does not work well and cells cannot move and recycle vesicles normally. This stresses long axons and contributes to their degeneration. Wikipedia+1

7. Defective autophagosome organization
   SPG11 is involved in the organization of autophagosomes, the “recycling bins” of the cell. Poor autophagy means damaged proteins and cell parts build up in neurons, which over many years damages axons and peripheral nerves. UniProt+1

8. Axonal transport failure
   Spatacsin helps maintain cytoskeleton stability and axo-dendritic transport. Without it, the long transport corridors inside axons break down. Nutrients and cell signals then cannot reach the ends of the nerves in the feet and hands, leading to axonal dying-back. Human Protein Atlas+1

9. Degeneration of corticospinal tracts
   In many SPG11 cases, there is slow damage to the long motor pathways from the brain to the spinal cord (corticospinal tracts). This degeneration makes leg weakness and walking problems worse, adding spasticity to the CMT-like neuropathy. PMC+1

10. Thin corpus callosum and white matter changes
    SPG11 mutations often cause thinning of the corpus callosum and other white matter changes. These reflect loss of long brain axons and can be part of the same degenerative process that affects peripheral nerves. PMC+1

11. Secondary mitochondrial stress in neurons
    Chronic problems with vesicle trafficking and autophagy can strain the energy systems of neurons. This secondary mitochondrial stress does not cause the disease by itself, but may accelerate axonal damage in already vulnerable SPG11-deficient neurons. ScienceDirect+1

12. Accumulation of toxic cellular waste
    Because waste removal is impaired, unwanted proteins and lipids can accumulate in nerve cells. Over time, this build-up harms the cell structure and contributes to progressive loss of axons in peripheral nerves. Wikipedia+1

13. Damage to distal motor axons
    In CMT2X, the most distant parts of motor nerves, especially those reaching the feet, are the first to fail. This “length-dependent” damage explains why foot weakness, foot drop and distal leg wasting are early and prominent features. Ovid+1

14. Damage to distal sensory axons
    Sensory nerve fibers carrying touch, pain and vibration from the feet and hands are also affected. Their gradual loss leads to numbness, reduced vibration sense and loss of protective sensation. NCBI+1

15. Genetic modifiers in other neuropathy genes
    Some patients carry additional variants in other neuropathy genes. These may not cause disease alone but can modify age at onset or severity when combined with SPG11 mutations, explaining variability even within families. PubMed+1

16. Consanguinity and small gene pools
    In families where parents are related or come from small, isolated populations, the chance that both carry the same SPG11 mutation is higher. This increases the risk of children with autosomal recessive CMT2X. PMC+1

17. Coexisting metabolic diseases (e.g., diabetes)
    Conditions like diabetes, vitamin deficiencies or thyroid disease do not cause SPG11 CMT2X, but they can add extra nerve damage. This can make symptoms worse and speed up disability in someone who already has the genetic disease. Mayo Clinic+1

18. Neurotoxic medications and toxins
    Some chemotherapy drugs, alcohol, and industrial toxins can damage peripheral nerves. In a person with SPG11-related neuropathy, such exposures can worsen weakness and numbness, although they are not the primary cause. ScienceDirect+1

19. Mechanical stress and repeated injuries to feet
    Because sensation and strength in the feet are low, small injuries or pressure points may go unnoticed. Over time, repeated trauma and poor footwear can add pain, deformity and secondary problems to the underlying neuropathy. Mayo Clinic

20. Aging of the nervous system
    As everyone ages, nerve conduction slows slightly. In a person with SPG11-related axonal loss, normal aging changes can further reduce nerve reserve, so weakness and balance problems may become more obvious in later life. ScienceDirect+1

---

Symptoms

1. Slowly progressive distal leg weakness
   The most typical symptom is slow loss of strength in the lower legs. People may find it hard to climb stairs, stand on tiptoe, or keep up with peers. The weakness worsens over years rather than days or weeks. MalaCards+1

2. Foot drop and tripping
   Weakness of the muscles that lift the front of the foot causes foot drop. The toes catch on the ground while walking, leading to frequent tripping or falls. People may develop a high-stepping gait to avoid dragging the toes. Mayo Clinic+1

3. Muscle wasting in the lower legs (“stork legs”)
   Because the nerves no longer activate the muscles properly, the muscles below the knees gradually shrink. This can give the legs a thin, “stork-like” appearance, even when the thighs look normal. NCBI+1

4. Foot deformities (pes cavus and hammertoes)
   Many patients develop high-arched feet (pes cavus) and toes that curl downward (hammertoes). These deformities come from long-standing muscle imbalance and can make shoe fitting and walking more difficult. NCBI+1

5. Numbness and reduced sensation in feet
   Loss of sensory fibers leads to numbness, tingling or “pins and needles” in the soles and toes. People may not feel small injuries or blisters, which can become infected if not noticed. NCBI+1

6. Weakness and wasting of hand muscles
   As the disease advances, the hands can also become weak and wasted. Tasks such as buttoning clothes, writing, typing or opening jars may become slow and tiring. MalaCards+1

7. Loss or reduction of tendon reflexes
   Deep tendon reflexes, like the ankle jerk and knee jerk, are often reduced or absent because of peripheral nerve damage. In some mixed CMT-HSP forms, reflexes may become brisk in the thighs while still absent at the ankles. NCBI+1

8. Gait imbalance and falls
   Weakness, sensory loss and foot deformities together cause poor balance. People may sway when they stand, especially with eyes closed, and falls are common, particularly on uneven ground or in the dark. Mayo Clinic+1

9. Neuropathic pain or discomfort
   Some patients experience burning, shooting pains, cramps or uncomfortable tingling in their feet and calves. These pains come from injured nerves sending abnormal signals, even when the limb looks normal. Mayo Clinic+1

10. Leg stiffness and spasticity (in mixed forms)
    In SPG11 cases where corticospinal tracts are involved, legs may feel stiff or tight. People can have scissoring of the legs when walking, and muscle spasms or clonus, showing combined peripheral and central motor damage. PMC+1

11. Fatigue and reduced walking distance
    Because walking requires much more effort with weak and stiff muscles, many people tire easily. They may need to rest after short distances or may start using canes, walkers or wheelchairs as the disease progresses. MDPI+1

12. Mild difficulties with thinking or planning (some cases)
    In individuals with thin corpus callosum or other brain changes, there can be mild problems with attention, planning, or processing speed. School or work performance may be affected, even though many people remain fully oriented and independent for a long time. PMC+1

13. Speech or swallowing difficulties (rare)
    Rarely, if bulbar regions are affected, some patients can develop mild speech slurring or swallowing difficulties similar to those seen in juvenile ALS. This is more common in SPG11 cases at the ALS end of the spectrum than in pure CMT2X. PubMed+1

14. Scoliosis or spine curvature
    Long-standing muscle imbalance in the trunk and lower limbs may lead to side-to-side curvature of the spine (scoliosis). This can cause back pain and cosmetic concerns and may need orthopedic care. Mayo Clinic+1

15. Emotional stress and reduced quality of life
    Living with a chronic, progressive, hereditary disease can cause sadness, anxiety or frustration. Limitations in walking and hand use can affect work, education and social life, so psychological and social support are important aspects of care. MDPI+1

---

Diagnostic tests

Doctors diagnose autosomal recessive CMT type 2 due to SPG11 mutation by combining clinical signs, nerve tests, imaging, and genetic testing. They also do tests to rule out other common causes of neuropathy. Below are 20 important diagnostic tools, grouped into categories.

---

Physical exam tests

1. Full neurological examination
   The doctor checks muscle strength, tone, reflexes, coordination and sensation in all limbs. They look for a pattern of distal weakness, wasting, areflexia and sensory loss that matches an axonal CMT and note any spasticity that might suggest SPG11-related pyramidal involvement. Mayo Clinic+1

2. Focused motor examination of legs and feet
   Using simple bedside maneuvers, the examiner tests ankle dorsiflexion, plantar flexion and toe movements. Early weakness of ankle dorsiflexors and evertors is typical. Over time, they may see severe atrophy of the calf and intrinsic foot muscles. NCBI+1

3. Reflex testing (deep tendon reflexes)
   The clinician taps the knee and ankle tendons to check reflexes. In pure CMT2X, ankle jerks are often absent because of nerve damage. In mixed SPG11 forms, knee reflexes can be brisk, showing both lower and upper motor neuron involvement in the same patient. PMC+1

4. Sensory examination
   Doctors test light touch, vibration, position sense and pain using tools like cotton wool, tuning forks and pins. A length-dependent sensory loss pattern, worse in the feet than in the hands, supports an axonal sensorimotor neuropathy such as CMT2X. NCBI+1

---

Manual tests

5. Manual muscle testing with grading scales
   Using manual resistance, the doctor grades muscle strength in key muscle groups of the ankles, knees, hips and hands, often using the Medical Research Council (MRC) scale. This gives a simple, repeatable way to track progression over time. MDPI+1

6. Gait observation and heel-toe walking
   Patients are asked to walk normally, on their heels, and on their toes. Observation of foot drop, high-stepping gait, poor heel walking and difficulty with toe walking gives important clues about distal weakness and balance problems. Mayo Clinic+1

7. Romberg balance test
   The patient stands with feet together, first with eyes open and then closed. Worsening sway or falls with eyes closed suggests sensory ataxia from loss of proprioceptive input in long sensory fibers, which is common in axonal CMT. Mayo Clinic+1

8. Functional hand tests
   Simple bedside tasks such as buttoning a shirt, writing, picking up small objects or turning a key can show subtle hand weakness and loss of fine motor control. These tasks reflect real-life disability better than strength numbers alone. Mayo Clinic+1

---

Lab and pathological tests

9. Basic blood tests to rule out acquired neuropathy
   Doctors usually check blood sugar, B12, folate, thyroid function, kidney and liver function, and sometimes inflammatory markers. Normal results support a hereditary cause like SPG11 CMT2X when combined with a compatible clinical picture. Mayo Clinic+1

10. Tests for autoimmune or toxic neuropathies (when needed)
    Depending on the case, additional tests such as autoimmune panels or toxin screens may be done. These help exclude treatable neuropathies, ensuring that SPG11 CMT2X is not diagnosed too quickly when another cause might be present. ScienceDirect+1

11. Targeted SPG11 genetic sequencing
    Once axonal CMT is suspected, a genetic test that directly sequences the SPG11 gene can be ordered. Finding two pathogenic variants in SPG11 confirms SPG11-related disease and can explain a CMT2X phenotype in the right clinical context. MedlinePlus+1

12. Expanded hereditary neuropathy gene panel
    Many labs offer panels that test dozens or hundreds of neuropathy genes at once. These panels can detect SPG11 mutations and also identify other genes that might modify the phenotype, giving a fuller genetic picture in complex cases. MDPI+1

13. Sural nerve biopsy (selected cases)
    A small sample of a sensory nerve, usually at the ankle, is removed and examined under a microscope. In CMT2X, findings often show axonal loss rather than severe demyelination. Today, nerve biopsy is used less often because genetic testing is more accurate and less invasive. Ovid+1

---

Electrodiagnostic tests

14. Motor nerve conduction studies (NCS)
    Electrodes stimulate and record responses from motor nerves in the legs and arms. In axonal CMT2X, the size of the responses is reduced (low amplitudes), while conduction velocities are often only mildly slowed, confirming an axonal neuropathy. Ovid+1

15. Sensory nerve conduction studies
    Similar tests are done on sensory nerves. Reduced or absent sensory responses in the feet and sometimes the hands are common. Together with motor NCS, this shows a length-dependent axonal sensorimotor neuropathy typical of CMT2 forms. NCBI+1

16. Electromyography (EMG)
    A thin needle electrode is inserted into muscles to record their electrical activity. EMG in CMT2X often shows signs of chronic denervation and reinnervation, such as large motor unit potentials, without evidence of primary muscle disease. Ovid+1

17. Somatosensory evoked potentials (SSEP) (selected cases)
    In some SPG11 patients with suspected central involvement, SSEPs check conduction from peripheral nerves to the brain. Delays in these signals can show additional involvement of central pathways beyond the peripheral neuropathy. PMC+1

---

Imaging tests

18. MRI of the brain
    Brain MRI can show a thin corpus callosum, white matter signal changes and cortical atrophy in many SPG11 cases. In someone with CMT-like neuropathy and these MRI findings, doctors strongly suspect SPG11-related disease and order genetic testing. PMC+1

19. MRI of the spine
    Spine MRI looks at the spinal cord and roots. It can help exclude compressive causes of weakness and may show subtle thinning or signal changes in corticospinal tracts, supporting the diagnosis of a hereditary neurodegenerative process. PMC+1

20. X-rays or CT of feet and ankles
    Simple X-rays are useful to document the degree of pes cavus, hammertoes and other bony deformities. This information helps orthopedic surgeons and physiatrists plan braces, insoles or surgical corrections to improve mobility and comfort. Mayo Clinic+1

21. Peripheral nerve ultrasound or MR neurography (where available)
    High-resolution ultrasound or special MRI techniques can visualize peripheral nerves. In axonal CMT2X, nerves are often of normal or only slightly increased size, supporting an axonal rather than demyelinating form and helping distinguish CMT2X from other neuropathies. ScienceDirect+1

Non-Pharmacological Treatments (Therapies and Others)

1. Strength and balance physiotherapy
   Regular physiotherapy uses simple exercises for the hips, knees, ankles, and core muscles. The goal is to keep muscles as strong as possible and slow down weakness. The therapist starts with very gentle, low-impact movements and slowly increases difficulty. This helps walking, standing, and transfers. It can also lower the risk of falls and joint stiffness. PMC+2Physiopedia+2

2. Stretching to reduce spasticity and contracture
   Daily slow stretches for the calves, hamstrings, hip flexors, and foot muscles help keep joints straight. This is important when there is leg stiffness from spasticity and nerve damage. Stretches are held for many seconds without bouncing. Over time, stretching can delay fixed deformities and make walking and standing less painful. SciELO+1

3. Ankle-foot orthoses (AFOs)
   Plastic or carbon braces around the ankle and foot support weak muscles that cause foot drop. They keep the ankle in a safe position, prevent tripping, and help the person walk more smoothly. Good AFOs can reduce energy use when walking and protect the joints from extra stress. A specialist orthotist custom-fits them. Pod NMD+1

4. Foot orthoses and shoe adaptations
   Soft insoles, arch supports, and custom shoes help correct high-arched or twisted feet, which are common in CMT. They spread pressure more evenly across the foot. This reduces pain, calluses, and skin breakdown. Proper footwear also improves balance and confidence during walking. Pod NMD+1

5. Occupational therapy (OT)
   Occupational therapists teach easier ways to do daily tasks like dressing, bathing, writing, and computer work. They may suggest tools such as grab bars, raised toilet seats, adapted cutlery, or writing aids. OT focuses on saving energy, staying safe at home and school, and supporting independence for as long as possible. Charcot-Marie-Tooth Association+1

6. Gait training and walking aids
   Physiotherapists can train safe walking patterns on flat ground, slopes, and stairs. They may introduce canes, crutches, or walkers when needed. Proper instruction on how to use these aids can greatly reduce falls. Training also improves confidence and encourages regular movement. PMC+1

7. Hydrotherapy (water-based exercise)
   Exercising in warm water supports body weight and makes movement easier. People can practice walking, stretching, and strengthening with less pain. The warmth can relax tight muscles. Hydrotherapy is helpful for those who tire quickly on land but still benefit from active exercise.

8. Balance and proprioception training
   Special exercises challenge the body to stay upright on different surfaces or with eyes closed. These “balance drills” help the brain use vision and remaining sensation more effectively. This can reduce falls even when nerve damage is severe. Simple tools like balance boards or foam mats are often used. ScienceDirect+1

9. Spasticity positioning and night splints
   When spasticity is strong, the legs and feet may pull into abnormal positions. Night splints or special cushions keep them in a better alignment for many hours during sleep. This gentle, long-term stretch helps reduce morning stiffness and delays fixed contractures. SciELO+1

10. Podiatry and skin care
    A podiatrist regularly trims nails, treats calluses, and checks for sores. Because feeling in the feet can be reduced, wounds may go unnoticed. Regular foot checks, moisturizing creams, and proper socks help prevent ulcers and infections, which can be serious. Pod NMD+1

11. Speech and swallowing therapy (when needed)
    Some people with SPG11-related disease develop speech or swallowing difficulties. A speech-language therapist can teach strategies for clearer speech and safer eating. This may include posture adjustments, food texture changes, and specific exercises for the mouth and throat muscles. PMC+1

12. Cognitive and educational support
    When mild thinking or learning problems are present, early evaluation and school support plans are vital. Simple language, repeated instructions, and visual aids can make learning easier. Psychological support can also help with frustration and low mood. PMC+2Frontiers+2

13. Psychological counseling and family support
    Living with a progressive nerve disease can cause sadness, anxiety, or anger. Counseling offers a safe place to talk about fears and future planning. It also supports parents and siblings who act as caregivers. Group sessions or patient organizations can reduce feelings of isolation. SciELO+1

14. Energy conservation and fatigue management
    Occupational therapists teach “work-simplifying” techniques such as sitting for tasks, pacing activities, resting before tiredness, and planning the day. These methods help people do more without feeling completely exhausted. They also prevent overuse of weak muscles. Charcot-Marie-Tooth Association+1

15. Respiratory monitoring and breathing exercises
    In advanced cases, trunk weakness or scoliosis can affect breathing. Regular lung function tests can detect early problems. Simple breathing exercises and supported coughing can help keep the lungs clear and reduce infection risk.

16. Nutrition counseling
    A dietitian can design a healthy, balanced diet to keep body weight in a safe range. Extra weight stresses weak legs and makes walking harder. Good nutrition also supports immunity and wound healing. Hydration is important for muscle and joint health.

17. Assistive technology and environmental modifications
    Wheelchairs, scooters, standing frames, and stairlifts may be introduced when walking becomes very difficult. Home changes such as ramps, widened doors, or bathroom grabs increase safety and independence. These changes should be planned early, before a crisis occurs.

18. Vocational and school guidance
    Because this disease progresses slowly, early career and school planning is helpful. Occupational and vocational specialists can suggest jobs and study paths that fit the person’s strengths and physical limits. This supports long-term independence and emotional health.

19. Genetic counseling for the family
    Genetic counselors explain how SPG11-related CMT2 is inherited and discuss carrier testing for family members. They also talk about options for future pregnancies, such as prenatal or preimplantation genetic testing. This helps families make informed choices. National Organization for Rare Disorders+1

20. Participation in clinical research
    Because SPG11-related CMT2 is very rare, clinical trials and natural-history studies are important. Taking part in research may give access to new ideas like gene therapy or neuroprotective drugs. It also helps scientists understand the disease better for future patients. PMC+2ResearchGate+2

---

Drug Treatments

There is no drug approved specifically to cure SPG11-related Charcot-Marie-Tooth disease type 2. The medicines below are commonly used for neuropathic pain, spasticity, mood, or other symptoms. Many are FDA-approved for related conditions and used off-label for CMT. Doses and schedules must always be set by a doctor using the official prescribing information (for example, from accessdata.fda.gov). FDA Access Data+3PMC+3ScienceDirect+3

1. Gabapentin
   Gabapentin is an anti-seizure medicine that is widely used to treat neuropathic pain (nerve pain) in conditions like diabetic neuropathy and post-herpetic neuralgia. It reduces abnormal firing of damaged nerves and can lower burning, tingling, and shooting pains. It is usually taken several times per day and the dose is slowly increased. Common side effects include sleepiness, dizziness, and weight gain. FDA Access Data+4FDA Access Data+4FDA Access Data+4

2. Pregabalin
   Pregabalin is similar to gabapentin and is approved for neuropathic pain in several conditions. It calms over-excited pain pathways in the spinal cord. It is often taken once or twice a day. It may act faster than gabapentin but can cause dizziness, drowsiness, and swelling in the legs. Doctors choose between these two based on response and side-effect profile.

3. Duloxetine
   Duloxetine is an antidepressant of the SNRI class. It is approved for neuropathic pain in diabetes and for chronic musculoskeletal pain. It increases serotonin and norepinephrine in the brain and spinal cord, which can reduce pain messages and improve mood. It is taken once daily. Side effects include nausea, dry mouth, and sometimes sleep changes.

4. Amitriptyline
   Amitriptyline is an older antidepressant often used at low dose for nerve pain. It changes pain signals in the spinal cord and helps with sleep. It is usually taken at night because it can cause drowsiness. Dry mouth, constipation, and weight gain are common side effects. Doctors are careful with heart problems and in younger patients.

5. Carbamazepine or oxcarbazepine
   These anti-seizure drugs can help sudden, stabbing nerve pains. They work by stabilizing sodium channels in nerve cell membranes, making nerves less likely to fire abnormally. They need blood tests in long-term use because they can affect blood counts or liver function. Dizziness and double vision are possible side effects.

6. Topical lidocaine (patches or creams)
   Lidocaine patches or gels numb the skin over painful areas. They block sodium channels in small nerve fibers right under the skin. This can ease burning or shooting pain without many whole-body side effects. Skin irritation or rash is possible but usually mild.

7. Baclofen (oral)
   Baclofen is a GABA-B receptor agonist used to treat spasticity in conditions like multiple sclerosis and spinal cord injury. It reduces reflex over-activity in the spinal cord, which can decrease muscle stiffness and spasms in SPG11-related disease. The dose is increased very slowly to avoid drowsiness and weakness. Abrupt stopping can be dangerous, so doctors taper it gradually. FDA Access Data+5FDA Access Data+5FDA Access Data+5

8. Tizanidine
   Tizanidine is another medicine for spasticity. It acts on alpha-2 receptors in the spinal cord to reduce muscle tone. It is taken in small doses several times a day. Side effects can include low blood pressure, sleepiness, and dry mouth, so doctors monitor carefully and adjust dose slowly.

9. Intrathecal baclofen (pump)
   For very severe spasticity that does not respond to tablets, baclofen can be given through a pump implanted under the skin, with a tube into the spinal fluid. This allows strong local action with lower blood levels. It can greatly reduce stiffness and pain, but requires surgery, pump refills, and close monitoring by a team. FDA Access Data+1

10. Botulinum toxin injections
    Botulinum toxin can be injected into specific spastic muscles, such as calf muscles causing toe-walking. It blocks the release of acetylcholine at the neuromuscular junction and temporarily weakens the muscle. This can improve posture, make physiotherapy easier, and delay contractures. Effects last a few months and injections are repeated as needed.

11. Non-steroidal anti-inflammatory drugs (NSAIDs)
    Medicines like ibuprofen or naproxen can help musculoskeletal pain from joint strain and deformity. They reduce inflammation by blocking COX enzymes. They are useful for short periods but can irritate the stomach and affect kidneys, so long-term use must be supervised.

12. Acetaminophen (paracetamol)
    Paracetamol is a simple pain reliever for mild aches and pains. It does not treat neuropathic pain directly but can reduce overall discomfort and make sleep easier. It is relatively safe when taken at proper doses but can harm the liver in overdose.

13. Low-dose opioids (in selected severe cases)
    In rare, severe pain not controlled by other drugs, a doctor may consider short-term use of weak opioids like tramadol. They act on opioid receptors and may also affect serotonin and norepinephrine. Because of risks of dependence, constipation, and drowsiness, they are used very cautiously and often avoided in young people.

14. Selective serotonin reuptake inhibitors (SSRIs)
    Medicines like sertraline or fluoxetine may be used when depression or anxiety develops. They increase serotonin levels in the brain. Better mood and less anxiety can also reduce the experience of pain and fatigue. Treatment usually takes weeks to show full benefit.

15. Melatonin or other sleep aids
    When pain, spasticity, or worry disturb sleep, doctors may suggest melatonin or short-term sleep medication. Good sleep improves daytime energy, mood, and participation in physiotherapy. Sleep medicines must be used carefully to avoid dependence and morning drowsiness.

16. Anticholinergic bladder medicines
    Some patients with SPG11-related disease may have bladder urgency or frequency. Drugs like oxybutynin relax the bladder muscle and reduce leakage. They can cause dry mouth and constipation, so doctors balance benefits and risks.

17. Laxatives and stool-softeners
    Reduced mobility and some medicines, such as baclofen, can cause constipation. Gentle laxatives and stool-softeners help keep bowel movements regular and comfortable. This supports better appetite, sleep, and quality of life.

18. Vitamin D and calcium supplements (when deficient)
    When tests show low vitamin D or calcium, supplements support bone health. Strong bones are important because falls are more likely with weak legs and poor balance. Doses are based on blood levels and age.

19. Multivitamin supplements (if diet is poor)
    A simple multivitamin is sometimes used when eating is difficult or appetite is low. It is not a specific treatment for SPG11-CMT2 but can prevent general vitamin deficiencies that might make fatigue and weakness worse.

20. Vaccines (as recommended)
    Vaccines for influenza, pneumonia, and other infections do not treat the nerve disease but protect health. Avoiding serious infections reduces hospital stays and prevents extra weakness and deconditioning. Vaccination schedules follow national guidelines.

---

Dietary Molecular Supplements

Evidence for supplements in SPG11-related CMT2 is limited. Most data come from studies in other neuropathies. Always ask a doctor before starting any supplement.

1. Vitamin B12
   Vitamin B12 is essential for myelin, the protective covering of nerves. Low B12 can worsen numbness and weakness. If blood tests show deficiency, injections or high-dose tablets are given. In people with normal B12, extra doses do not cure SPG11-CMT2 but may support general nerve health.

2. Folate (Vitamin B9)
   Folate is needed for DNA repair and cell division. Low folate can also contribute to neuropathy. Correcting deficiency with tablets can improve overall health but does not reverse genetic nerve damage. Doctors often check B12 and folate together.

3. Vitamin D
   Vitamin D supports bone strength, muscle function, and immunity. Deficiency is common in people who walk less or stay indoors. Supplementation based on blood levels can reduce fracture risk and may improve muscle performance slightly.

4. Omega-3 fatty acids (fish oil)
   Omega-3 fats have anti-inflammatory effects and may support nerve cell membranes. Some studies in diabetic neuropathy suggest they can modestly improve nerve function. They are usually taken as capsules with meals. Side effects can include fishy aftertaste and mild stomach upset.

5. Alpha-lipoic acid
   Alpha-lipoic acid is an antioxidant that has been studied in diabetic neuropathy. It may reduce oxidative stress in nerves and slightly improve pain in some patients. Doses and safety must be discussed with a doctor, especially in young people or those with thyroid problems.

6. Acetyl-L-carnitine
   This compound helps transport fatty acids into mitochondria, the energy centers of cells. Some small studies suggest it may support nerve regeneration and reduce pain. It is usually taken as oral capsules. Stomach upset and restlessness are possible.

7. Coenzyme Q10
   CoQ10 is involved in mitochondrial energy production. It is sometimes used when mitochondrial involvement is suspected. Evidence in CMT is limited, but it may help overall energy levels in some people. It is usually well tolerated.

8. Magnesium
   Magnesium helps muscle relaxation and nerve signaling. Mild deficiency can worsen cramps and fatigue. Supplements must be used carefully in people with kidney disease. Too much can cause diarrhea and, rarely, low blood pressure.

9. Curcumin (turmeric extract)
   Curcumin has anti-inflammatory and antioxidant properties in laboratory studies. It is sometimes used as a general anti-inflammatory supplement. Its direct effect on CMT nerves is unknown, but it may help joint and muscle discomfort.

10. Resveratrol
    Resveratrol is a plant compound with antioxidant effects. Research in animals suggests possible neuroprotective effects, but evidence in humans with CMT is very limited. If used, it should be considered experimental and only with medical advice.

---

Immunity-Booster / Regenerative / Stem Cell Drug Concepts

There are no approved regenerative or stem cell drugs for SPG11-related CMT2 at this time. The items below describe research ideas and general approaches, not routine treatments. PMC+2ResearchGate+2

1. Gene therapy targeting SPG11
   Researchers are exploring ways to deliver a correct copy of the SPG11 gene to nerve cells using viral vectors. The goal is to restore normal protein function and slow or stop nerve damage. This work is still in early research and not available as standard care.

2. CRISPR-based gene editing
   Future strategies may use CRISPR technology to correct SPG11 mutations directly in DNA. So far, this is experimental and tested mainly in cells and animal models. Safety, accuracy, and long-term effects must be carefully studied before human use.

3. Neurotrophic factor therapies
   Drugs or biologics that mimic brain-derived neurotrophic factor (BDNF) or other growth factors may help support survival of damaged neurons. These treatments aim to protect nerves from further degeneration. Clinical trials in related diseases are ongoing.

4. Mesenchymal stem cell therapy
   Mesenchymal stem cells from bone marrow or fat are being studied as possible ways to release helpful growth factors and modulate inflammation. There is no strong evidence yet for SPG11-CMT2, and such treatments should only be taken within approved trials.

5. Small-molecule neuroprotective drugs
   Some experimental drugs target mitochondrial function, oxidative stress, or protein handling inside neurons. The idea is to make nerve cells more resistant to damage. Several such compounds are being tested in other neurodegenerative diseases and may later be tried in genetic neuropathies.

6. Immune-modulating biologics
   Although SPG11-CMT2 is not primarily an immune disease, some researchers are exploring whether low-level inflammation contributes to nerve damage. Modern biologics that control inflammation are being tested in many conditions. At present, they are not standard for SPG11-CMT2 and should not be used outside trials.

---

Surgeries (Procedures and Why They Are Done)

1. Foot deformity correction (osteotomy)
   In people with very high arches or twisted feet, surgeons may cut and realign bones in the foot (osteotomy) and hold them with screws or plates. This aims to create a flatter, more stable foot. It can improve standing, walking, and shoe fitting, and may reduce pain and skin breakdown. PMC+1

2. Tendon transfer surgery
   When certain muscles are very weak and others are stronger, surgeons can move a tendon from a stronger muscle to help lift the foot or straighten toes. This balances forces around the ankle and may reduce foot drop. It is usually done after growth and with careful physiotherapy before and after surgery.

3. Joint fusion (arthrodesis)
   If joints in the foot or ankle are unstable and painful, surgeons may fuse them so they do not move. This can give a more solid base to stand on, at the cost of some flexibility. Fusion is often used after other surgeries or when deformity is very advanced.

4. Spine surgery for scoliosis
   In some patients, weak trunk muscles and abnormal posture lead to significant curvature of the spine (scoliosis). If braces and physiotherapy are not enough, surgeons may straighten and stabilize the spine using rods and screws. This can improve sitting balance, lung function, and comfort.

5. Intrathecal baclofen pump implantation
   As noted above, a small pump can be placed under the skin with a catheter into the spinal fluid to deliver baclofen directly. This surgery is considered when oral spasticity drugs do not control stiffness or cause too many side effects. It requires ongoing refills and monitoring. FDA Access Data+1

---

Preventions and Protective Measures

You cannot prevent being born with an SPG11 mutation, but you can reduce complications and protect function:

1. Genetic counseling before having children.

2. Early physiotherapy and orthoses to delay deformities.

3. Daily stretching to prevent contractures.

4. Safe home environment to prevent falls (no loose rugs, good lighting).

5. Regular podiatry and daily foot checks to prevent ulcers.

6. Vaccinations and early treatment of infections.

7. Healthy weight to reduce stress on weak legs.

8. Avoiding smoking and excess alcohol, which damage nerves.

9. Careful use of medicines that can harm nerves (only with doctor’s advice).

10. Regular follow-up with neurology and rehabilitation teams.

---

When to See Doctors

You should see a doctor or neurologist:

• When you notice new weakness, tripping, or changes in walking.

• If you develop new or severe pain, burning, or numbness.

• When leg stiffness or spasms increase and interfere with sleep or daily tasks.

• If you see foot sores, color changes, or swelling that do not quickly improve.

• When there are problems with speech, swallowing, or breathing.

• If mood becomes very low, or you feel hopeless or very anxious.

• Before starting, stopping, or changing any medicine or supplement.

• When planning surgery, pregnancy, or major life changes.

Regular reviews, often once or twice a year, help to adjust braces, therapies, and medicines at the right time. ScienceDirect+1

---

Things to Eat and Things to Avoid

There is no special “SPG11 diet”, but a healthy pattern supports muscles, bones, and overall health.

Good to eat (in balance)

1. Colorful vegetables – rich in vitamins, minerals, and antioxidants.

2. Fruits – provide vitamins, fiber, and natural sweetness.

3. Lean proteins (fish, chicken, beans, lentils, eggs) – support muscle repair.

4. Whole grains (brown rice, oats, whole-wheat bread) – give steady energy.

5. Healthy fats (olive oil, nuts, seeds, avocados) – support cell membranes and brain function.

6. Low-fat dairy or fortified alternatives – supply calcium and vitamin D.

7. Plenty of water – helps joints, muscles, and bowel function.

8. Foods rich in B vitamins (leafy greens, legumes, fortified cereals).

9. Foods rich in omega-3 (fatty fish like salmon, flaxseeds, walnuts).

10. High-fiber foods – help prevent constipation from low activity and medicines.

Better to limit or avoid

1. Sugary drinks and sweets – add empty calories and weight gain.

2. Very salty snacks – can increase blood pressure and swelling.

3. Deep-fried and fast foods – promote weight gain and inflammation.

4. Excess red and processed meats – may worsen general health if eaten often.

5. Large amounts of caffeine – can disturb sleep and worsen anxiety.

6. Alcohol – can damage nerves and impair balance, increasing fall risk.

7. Crash diets or very low-calorie diets – reduce muscle mass and energy.

8. Unregulated “miracle” supplements – may interact with medicines or be unsafe.

9. Very high vitamin doses without doctor advice – some vitamins can be toxic.

10. Smoking or vaping – harms circulation and nerve health.

---

Frequently Asked Questions (FAQs)

1. Is autosomal recessive Charcot-Marie-Tooth disease type 2 due to SPG11 mutation curable?
   No. At present there is no cure. Treatment focuses on symptoms, maintaining mobility, and preventing complications through therapy, braces, medicines, and sometimes surgery. Research into gene and stem cell therapies is ongoing. PMC+2ResearchGate+2

2. Will everyone with SPG11-related CMT2 end up in a wheelchair?
   Not always. Some people stay able to walk with aids for many years. Others may need a wheelchair for long distances but still walk short distances at home. Early physiotherapy and orthotics help keep walking ability for as long as possible.

3. How fast does this disease progress?
   Progression is usually slow over many years. Some people notice clear changes over 5–10 years, while others progress more gradually. The pattern can differ even within the same family. Regular monitoring helps track changes and adjust care. PMC+2Frontiers+2

4. Can exercise make the disease worse?
   Gentle, supervised exercise usually helps rather than harms. Over-exercising to the point of severe pain or exhaustion can strain weak muscles. A physiotherapist can design safe exercises that build strength and protect joints. PMC+1

5. Is this the same as hereditary spastic paraplegia (HSP)?
   SPG11 mutations most often cause HSP, but in some people they cause a CMT2-like picture or a mixed picture of both. Many patients have leg stiffness from HSP and nerve damage in the peripheral nerves like CMT. Doctors use clinical exam, imaging, and nerve tests to describe each case. PMC+2Frontiers+2

6. Can children with SPG11-CMT2 go to regular school?
   Many can, especially with early support such as physical and occupational therapy, accessible classrooms, and sometimes extra educational help. A team approach with teachers and therapists works best.

7. Will medicines like gabapentin or baclofen stop the disease from getting worse?
   No. These medicines reduce pain or spasticity but do not change the underlying genetic problem. They are important for comfort and function but are not disease-modifying. FDA Access Data+5FDA Access Data+5FDA Access Data+5

8. Is it safe to become pregnant with this condition?
   Many women with CMT can have successful pregnancies, but planning is important. Medicines may need adjustment before and during pregnancy. Genetic counseling can explain the chance of the baby inheriting the condition. Pregnancy decisions should be made with neurologist and obstetrician support.

9. Can SPG11-CMT2 affect life expectancy?
   For many people, life expectancy is near normal, especially with good care for mobility, nutrition, and breathing. Severe complications like lung infections or major falls can increase risk, so prevention and early treatment are important.

10. Should brothers and sisters be tested?
    Genetic testing of siblings is a personal choice. Some families prefer to know, especially when planning careers or children. Others prefer not to test until certain age. A genetic counselor can guide these decisions.

11. Are stem cell clinics on the internet safe?
    Most “stem cell” treatments advertised online are not proven and may be unsafe. They can be very expensive and may not follow strict scientific or safety standards. Only participate in treatments offered within approved clinical trials run by recognized hospitals or universities.

12. Can diet alone treat this disease?
    No. A healthy diet supports general health and energy but cannot correct the genetic mutation or fully stop nerve damage. Diet should be used together with therapy, orthoses, medicines, and medical monitoring.

13. Is pain always part of SPG11-CMT2?
    No. Some people mainly have weakness and spasticity with little pain. Others develop burning, tingling, or aching pain from nerve damage and joint stress. Pain can usually be improved with medicines, physiotherapy, and orthotics.

14. How often should I have follow-up visits?
    This depends on age and disease stage, but many specialists suggest review every 6–12 months, or sooner if new symptoms appear. During visits, they check strength, walking, braces, medicines, mood, and any new concerns. ScienceDirect+1

15. What is the most important thing I can do today?
    The most important steps are: stay active with safe exercises, protect your feet, use braces or aids if advised, keep a healthy weight, and stay in regular contact with your care team. Small daily actions add up to big long-term benefits.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 23, 2025.